≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

Benign neoplasm: Duodenum

Endpoint Browser

CD2_BENIGN_DUODENUM_EXALLC

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

None

-

2. Check conditions

None

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — D13.2&
  • Hospital discharge: ICD-8 — 21121
  • Cause of death: ICD-10 — D13.2&
  • Cause of death: ICD-8 — 21121

2 out of 7 registries used, show all original rules.

-

4. Check minimum number of events

None

-

5. Include endpoints

None

-

6. Filter based on genotype QC (FinnGen only)

None

-

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D13
Name in latin
Neoplasma benignum duodeni

Case counts by codes

↥

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 852 447 405
Unadjusted period prevalence (%) 0.16 0.15 0.18
Median age at first event (years) 66.55 66.10 67.03

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
775
Matched controls
7750
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D13.2
ICD-10 Finland
Benign neoplasm: Duodenum
+∞
323.0
764
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
27.5
313.1
679
1584
UJF32
NOMESCO Finland
Coloscopy
5.5
98.8
401
1272
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
47.2
96.0
117
29
D13.1
ICD-10 Finland
Benign neoplasm: Stomach
20.6
85.3
130
75
130
Kela drug reimbursment
Malignant tumour
+∞
66.6
63
*
JDH05
NOMESCO Finland
Endoscopic polypectomy in duodenum
+∞
57.0
54
*
D37.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Small intestine
204.7
55.8
57
*
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
8.1
50.3
120
172
JN4BD
NOMESCO Finland
Extensive body CT
7.7
50.1
124
188
D13.3
ICD-10 Finland
Benign neoplasm: Other and unspecified parts of small intestine
139.1
49.4
52
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
177.8
48.4
50
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
48.4
46
*
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
17.8
48.0
76
47
JN3BD
NOMESCO Finland
Extensive abdominal CT
5.2
47.8
163
374
A02BC02
ATC
pantoprazole; systemic
3.3
46.1
601
3975
A03FA01
ATC
metoclopramide; systemic, rectal
4.6
44.9
176
466
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
7.3
44.7
113
176
115
Kela drug reimbursment
Breast cancer
+∞
42.1
40
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
12.3
41.6
77
69
JLC30
NOMESCO Finland
Pancreatoduodenectomy
216.0
40.2
41
*
JDA05
NOMESCO Finland
Endoscopic polypectomy in stomach or pylorus
41.0
40.2
50
13
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
47.6
37.3
45
10
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.8
36.5
335
1668
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
4.0
35.6
159
468
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
5.0
35.5
122
277
D64.9
ICD-10 Finland
Anaemia, unspecified
4.2
35.2
150
423
H02AB02
ATC
dexamethasone; systemic
15.6
35.1
58
40
UJF92
NOMESCO Finland
Capsular endoscopy
14.4
35.1
60
45
A04AA02
ATC
granisetron; systemic, transdermal
125.6
34.0
36
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.3
33.6
200
740
116
Kela drug reimbursment
Prostate cancer
+∞
32.5
31
*
JN4AD
NOMESCO Finland
Body CT examination
7.8
32.1
76
106
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.8
32.0
150
458
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.5
31.8
416
2470
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
31.5
30
*
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
4.1
31.0
130
359
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
86.1
30.0
33
*
WX002
NOMESCO Finland
Sedation and analgesia
2.9
29.9
225
967
A09AA02
ATC
multienzymes (lipase, protease etc.)
11.5
29.2
55
51
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
2.8
28.7
218
937
UJF30
NOMESCO Finland
Ileoscopy through colon
4.0
28.6
124
351
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
28.3
27
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.6
27.6
246
1161
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
27.2
26
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
100.3
26.8
29
*
PJA12
NOMESCO Finland
Sentinel node biopsy
145.0
26.8
28
*
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
3.4
26.7
143
481
A02BC05
ATC
esomeprazole; systemic
2.3
26.5
382
2303
WX402
NOMESCO Finland
General anaesthesia
3.3
26.1
150
532
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.5
26.1
250
1223
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
17.2
26.1
41
25
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
269.1
25.8
26
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
5.6
25.7
78
152
TPH04
NOMESCO Finland
Cathetrisation of vein
2.7
25.1
205
913
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
3.9
25.0
112
325
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
4.1
24.9
103
278
D12.8
ICD-10 Finland
Benign neoplasm: Rectum
5.8
24.8
73
137
D12.3
ICD-10 Finland
Benign neoplasm: Transverse colon
8.4
24.6
55
70
JJ1CE
NOMESCO Finland
Liver, bile duct and pancreas endoscopic ultrasound examination
35.8
24.4
31
9
ZX120
NOMESCO Finland
Intravenous
4.0
24.0
101
277
A02BC01
ATC
omeprazole; systemic
2.3
23.7
279
1503
D12.5
ICD-10 Finland
Benign neoplasm: Sigmoid colon
5.7
23.4
69
130
UJF02
NOMESCO Finland
Peroral enteroscopy
37.6
23.1
29
8
L03AA13
ATC
pegfilgrastim; parenteral
+∞
23.0
22
*
L02BA01
ATC
tamoxifen; oral
123.6
22.7
24
*
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
11.6
22.6
42
38
L02AE02
ATC
leuprorelin; implant, parenteral
33.4
22.5
29
9
WF002
NOMESCO Finland
Radical radiotherapy
46.5
22.5
27
6
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
10.3
22.3
44
45
A04AA01
ATC
ondansetron; systemic, rectal
8.7
22.2
48
58
N02AA05
ATC
oxycodone; systemic
3.1
22.2
137
507
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
22.0
21
*
TPH07
NOMESCO Finland
Cathetrisation of artery
3.3
21.6
116
388
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
6.7
21.3
55
87
Z01.8
ICD-10 Finland
Other specified special examinations
2.4
21.3
212
1040
L02BG04
ATC
letrozole; oral
34.9
21.2
27
8
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.4
21.2
80
198
L01BC06
ATC
capecitabine; oral
+∞
20.9
20
*
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.7
20.9
168
731
Z51.5
ICD-10 Finland
Palliative care
7.8
20.7
48
65
JN3AD
NOMESCO Finland
Abdominal CT examination
3.8
20.5
90
256
K31.7
ICD-10 Finland
Polyp of stomach and duodenum
24.1
20.1
28
12
JDH52
NOMESCO Finland
Endoscopic mucosal or submucosal resection in duodenum
+∞
19.9
19
*
Z2221
NOMESCO Finland
Medical doctor
2.2
19.4
240
1299
R4110
NOMESCO Finland
Physiotherapy
2.2
19.0
231
1238
JFA05
NOMESCO Finland
Endoscopic polypectomy in small intestine
56.5
19.0
22
*
XX3DW
NOMESCO Finland
Time consuming IT work
4.9
18.8
63
138
JAH00
NOMESCO Finland
Laparotomy
8.4
18.7
41
51
B01AB05
ATC
enoxaparin; parenteral
2.1
18.7
259
1468
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.3
18.5
102
344
JN4CD
NOMESCO Finland
Very extensive body CT
8.3
18.5
41
52
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
5.8
18.5
53
97
D12.2
ICD-10 Finland
Benign neoplasm: Ascending colon
5.8
18.5
53
97
UJK02
NOMESCO Finland
ERCP
6.1
18.4
51
89
H02AB06
ATC
prednisolone; systemic
2.0
18.4
391
2635
K92.1
ICD-10 Finland
Melaena
4.2
18.3
71
180
ZXE30
NOMESCO Finland
More than five and less than seven hours
4.5
18.3
66
156
ZXE20
NOMESCO Finland
More than three and less than five hours
2.7
18.3
136
561
Z80.0
ICD-10 Finland
Family history of malignant neoplasm of digestive organs
22.4
18.3
26
12
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
12.3
17.9
32
27
N02BE01
ATC
paracetamol; systemic, rectal
2.4
17.9
676
5706
J01DB01
ATC
cefalexin; oral
2.2
17.6
626
5108
JDH50
NOMESCO Finland
Local excision of lesion of duodenal bulb
184.0
17.6
18
*
ZXE00
NOMESCO Finland
One hour or less
2.0
17.2
315
1987
WW500
NOMESCO Finland
Blood transfusion
7.0
17.0
42
63
ZXD10
NOMESCO Finland
Scheduled procedure
2.0
17.0
317
2013
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.0
16.7
105
390
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
16.7
16
*
C17.0
ICD-10 Finland
Malignant neoplasm: Duodenum
+∞
16.7
16
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.4
16.4
156
734
R4190
NOMESCO Finland
Nutritional therapy
7.6
15.9
37
51
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
17.6
15.7
24
14
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
15.7
15
*
NK6AN
NOMESCO Finland
Total body bone isotope imaging
26.9
15.6
21
8
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
5.7
15.6
45
83
ZX090
NOMESCO Finland
Other technic of radiotherapy
163.1
15.5
16
*
K30
ICD-10 Finland
Functional dyspepsia
2.7
15.4
111
448
ZXE10
NOMESCO Finland
More than one and less than three hours
1.9
15.3
290
1832
HAB40
NOMESCO Finland
Wedge excision of mammary gland
18.2
15.2
23
13
JDA52
NOMESCO Finland
Other endoscopic procedure using diathermy or heat in stomach or pylorus
32.4
14.9
19
6
N02AX02
ATC
tramadol; systemic, rectal
1.9
14.7
346
2350
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
14.6
14
*
HAC20
NOMESCO Finland
Total mastectomy
81.7
14.6
16
*
WZC30
NOMESCO Finland
Teaching
2.9
14.5
95
360
AA1AD
NOMESCO Finland
CT of head and brain
2.0
14.4
227
1332
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.8
14.4
101
400
Z3231
NOMESCO Finland
Registered nurse
2.0
14.3
228
1343
UJD02
NOMESCO Finland
Gastroscopy
3.6
14.3
65
190
HA1AA
NOMESCO Finland
X-ray mammography
5.2
14.3
44
88
Z3226
NOMESCO Finland
Physiotherapist
2.2
14.3
166
856
K22.1
ICD-10 Finland
Ulcer of oesophagus
6.2
14.2
38
64
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.9
14.2
274
1730
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
43.3
14.1
17
*
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
9.1
14.1
29
33
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
3.1
13.9
79
273
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
6.1
13.8
37
63
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
7.1
13.8
33
48
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
13.6
13
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
13.6
13
*
B80
ICPC
Iron deficiency anaemia
7.6
13.5
31
42
L02BB03
ATC
bicalutamide; oral
142.3
13.5
14
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
142.3
13.5
14
*
UJF14
NOMESCO Finland
Enteroscopy of ileoanal anastomosis
26.3
13.4
18
7
J45.9
ICD-10 Finland
Asthma, unspecified
2.1
13.3
164
866
A02BC03
ATC
lansoprazole; oral
1.9
13.3
270
1730
R07.4
ICD-10 Finland
Chest pain, unspecified
1.9
13.2
251
1568
L03AA02
ATC
filgrastim; parenteral
40.8
13.2
16
*
D13.6
ICD-10 Finland
Benign neoplasm: Pancreas
15.4
13.1
21
14
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
11.2
13.1
24
22
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
19.4
13.0
19
10
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
2.1
12.8
175
964
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
4.1
12.8
50
129
R03AC02
ATC
salbutamol; inhalant
1.7
12.6
399
2932
L02BG06
ATC
exemestane; oral
+∞
12.5
12
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
12.5
12
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
12.5
12
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
12.5
12
*
Z51.88
ICD-10 Finland
Other specified medical care
7.0
12.5
30
44
XW000
NOMESCO Finland
Bone marrow biopsy
4.7
11.9
40
89
R06.0
ICD-10 Finland
Dyspnoea
1.9
11.9
220
1351
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.7
11.8
52
149
J01MA12
ATC
levofloxacin; systemic
2.1
11.8
155
837
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
5.5
11.8
34
64
I10
ICD-10 Finland
Essential (primary) hypertension
1.7
11.8
506
4038
B01AB10
ATC
tinzaparin; parenteral
3.6
11.8
53
155
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
6.2
11.7
31
52
UJF12
NOMESCO Finland
Enteroscopy through intestinal stoma
30.5
11.7
15
5
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
8.3
11.6
25
31
D50.8
ICD-10 Finland
Other iron deficiency anaemias
8.3
11.6
25
31
Z46.9
ICD-10 Finland
Fitting and adjustment of unspecified device
7.3
11.6
27
38
C03CA01
ATC
furosemide; systemic
1.8
11.5
256
1671
3AC01
NOMESCO Finland
NA
13.9
11.5
19
14
A04AD12
ATC
aprepitant; systemic
+∞
11.5
11
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
11.5
11
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
11.5
11
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
11.5
11
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
11.5
11
*
L02BG03
ATC
anastrozole; oral
121.7
11.5
12
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
5.3
11.3
34
67
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
6.1
11.3
30
51
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.2
11.3
128
650
A06AD11
ATC
lactulose; oral
2.1
11.2
132
680
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
3.4
11.2
55
172
C07AB07
ATC
bisoprolol; oral
1.7
11.2
416
3159
K63.8
ICD-10 Finland
Other specified diseases of intestine
25.4
11.2
15
6
JLW98
NOMESCO Finland
Other transluminal endoscopic operation on pancreas
25.4
11.2
15
6
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
10.2
11.0
21
21
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
4.6
11.0
37
83
P01AB01
ATC
metronidazole; oral, rectal
1.7
11.0
295
2035
ZXA00
NOMESCO Finland
Right side
1.8
11.0
233
1494
D12.0
ICD-10 Finland
Benign neoplasm: Caecum
4.7
10.9
36
79
WX110
NOMESCO Finland
Local anesthesy
1.7
10.9
480
3812
K25.7
ICD-10 Finland
Gastric ulcer, Chronic without haemorrhage or perforation
8.4
10.9
23
28
J01MA02
ATC
ciprofloxacin; systemic
1.7
10.9
298
2070
JDA42
NOMESCO Finland
Other endoscopic haemostatic procedure in stomach or pylorus
18.1
10.8
16
9
JFB31
NOMESCO Finland
Laparoscopic right hemicolectomy
28.5
10.7
14
5
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.9
10.7
65
235
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.4
10.7
94
422
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
60.8
10.6
12
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.1
10.6
137
730
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
4.6
10.5
36
82
A02BA02
ATC
ranitidine; systemic
1.9
10.4
173
1019
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
111.4
10.4
11
*
21121
ICD-8 Finland
Benign neoplasm of other parts of digestive system, Duodeni
+∞
10.4
10
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
10.4
10
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.1
10.4
124
640
S18
ICPC
Laceration/cut
1.7
10.4
315
2239
Z12.1
ICD-10 Finland
Special screening examination for neoplasm of intestinal tract
12.2
10.4
18
15
ZXE40
NOMESCO Finland
More than seven and less than nine hours
5.4
10.4
30
57
Z13.5
ICD-10 Finland
Special screening examination for eye and ear disorders
6.2
10.4
27
45
R23.8
ICD-10 Finland
Other and unspecified skin changes
2.2
10.4
115
575
N05CF01
ATC
zopiclone; oral
1.7
10.3
266
1806
WX004
NOMESCO Finland
Patient-controlled sedation
19.1
10.3
15
8
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.5
10.3
82
351
M79.6
ICD-10 Finland
Pain in limb
1.7
10.2
282
1950
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.7
10.2
71
280
K31.8
ICD-10 Finland
Other specified diseases of stomach and duodenum
13.3
10.2
17
13
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.3
10.2
96
446
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.6
10.1
73
293
A06AC01
ATC
ispaghula (psylla seeds); oral
1.8
10.0
211
1342
K29.5
ICD-10 Finland
Chronic gastritis, unspecified
3.9
10.0
40
106
Z01.7
ICD-10 Finland
Laboratory examination
2.2
9.9
101
488
SPAT1236
SPAT
Informing family of child’s disability
4.1
9.6
36
90
WX892
NOMESCO Finland
Monitored bed care
2.5
9.6
77
329
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
5.8
9.6
26
46
K29.7
ICD-10 Finland
Gastritis, unspecified
3.7
9.6
41
116
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
9.2
9.6
19
21
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.2
9.5
104
518
XF400
NOMESCO Finland
ECG with 12 standard connections
1.9
9.5
147
840
R50.9
ICD-10 Finland
Fever, unspecified
2.2
9.5
99
484
C44.11
ICD-10 Finland
Basocellular carcinoma of the skin of the eyelids including the corner of the eye
101.2
9.4
10
*
JDH28
NOMESCO Finland
Other endoscopic procedure using diathermy or heat in duodenum
101.2
9.4
10
*
D13.0
ICD-10 Finland
Benign neoplasm: Oesophagus
30.4
9.4
12
*
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
6.0
9.4
25
43
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
+∞
9.4
9
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
9.4
9
*
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
9.4
9
*
C18.01
ICD-10 Finland
Malignant tumor of the caecum invasive carcinoma
+∞
9.4
9
*
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
+∞
9.4
9
*
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.5
9.4
75
319
Z98.8
ICD-10 Finland
Other specified postsurgical states
8.2
9.4
20
25
N03AX16
ATC
pregabalin; oral
1.8
9.3
192
1212
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.7
9.3
63
246
D12.4
ICD-10 Finland
Benign neoplasm: Descending colon
6.2
9.3
24
40
K29.8
ICD-10 Finland
Duodenitis
8.4
9.1
19
23
A07AA02
ATC
nystatin; oral
2.8
9.1
60
229
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.7
9.0
209
1368
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.9
9.0
143
828
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
3.7
9.0
38
107
R52.9
ICD-10 Finland
Pain, unspecified
2.4
8.9
73
316
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
4.0
8.9
34
87
K56.7
ICD-10 Finland
Ileus, unspecified
6.4
8.8
22
35
R13
ICD-10 Finland
Dysphagia
2.6
8.8
63
255
R12
ICD-10 Finland
Heartburn
2.5
8.8
66
274
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.3
8.7
85
402
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
50.5
8.7
10
*
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
50.5
8.7
10
*
ZXD05
NOMESCO Finland
Urgent procedure
1.7
8.7
230
1560
N03AX12
ATC
gabapentin; oral
1.9
8.6
128
720
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.2
8.5
90
440
A02BC04
ATC
rabeprazole; oral
2.3
8.5
78
356
B03BA03
ATC
hydroxocobalamin; parenteral
2.7
8.5
57
219
R02
ICPC
Shortness of breath/dyspnoea
2.0
8.5
107
565
K85.9
ICD-10 Finland
Acute pancreatitis, unspecified
5.2
8.5
25
49
AA1BD
NOMESCO Finland
Extensive CT of head and brain
5.2
8.5
25
49
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.6
8.5
320
2378
K29.3
ICD-10 Finland
Chronic superficial gastritis
3.3
8.5
42
134
ZJX00
NOMESCO Finland
Double balloon technique in gastroenterological endoscopy
91.0
8.4
9
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
91.0
8.4
9
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
91.0
8.4
9
*
JDA45
NOMESCO Finland
Endoscopic mucosal or submucosal resection in stomach or pylorus
91.0
8.4
9
*
Y77
ICPC
Malignant neoplasm prostate
91.0
8.4
9
*
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
91.0
8.4
9
*
A46
ICD-10 Finland
Erysipelas
2.0
8.4
119
656
X59
ICD-10 Finland
Exposure to unspecified factor
1.9
8.4
140
819
R11
ICD-10 Finland
Nausea and vomiting
2.6
8.4
63
259
TPX10
NOMESCO Finland
Implantation of vascular injection port
4.7
8.4
27
59
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
8.3
8
*
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
+∞
8.3
8
*
C18.20
ICD-10 Finland
Malignant tumor of the ascending colon without histology
+∞
8.3
8
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
8.3
8
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
8.3
8
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
8.3
8
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
8.3
8
*
TQW20
NOMESCO Finland
Tatoe
+∞
8.3
8
*
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
8.3
8
*
C18.21
ICD-10 Finland
Malignant tumor of the ascending colon invasive carcinoma
+∞
8.3
8
*
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.9
8.3
122
681
K83.0
ICD-10 Finland
Cholangitis
5.9
8.3
22
38
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.2
8.3
41
131
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
5.2
8.2
24
47
R51.80
ICD-10 Finland
Headache
2.0
8.2
106
566
CBB30
NOMESCO Finland
Excision of lesion of eyelid
4.1
8.1
30
75
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.3
8.1
71
319
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
33.7
8.1
10
*
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.9
8.0
46
163
Z31.5
ICD-10 Finland
Genetic counselling
4.4
7.9
27
63
M04AA01
ATC
allopurinol; systemic
1.9
7.9
113
626
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
10.9
7.8
14
13
I84.9
ICD-10 Finland
Unspecified hemorrhoids without complication
2.8
7.8
49
182
K83.1
ICD-10 Finland
Obstruction of bile duct
7.1
7.8
18
26
J01FF01
ATC
clindamycin; systemic
1.7
7.8
205
1379
XKD00
NOMESCO Finland
Uroflowmetry
1.9
7.8
114
637
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.9
7.7
116
656
WF003
NOMESCO Finland
Adjuvant radiotherapy
45.4
7.7
9
*
TJX22
NOMESCO Finland
Excision of local lesion in gastrointestinal endoscopy
45.4
7.7
9
*
JDH25
NOMESCO Finland
Other endoscopic haemostatic procedure in duodenum
45.4
7.7
9
*
JFB00
NOMESCO Finland
Partial resection of small intestine
6.0
7.7
20
34
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
3.4
7.7
36
111
N06AX21
ATC
duloxetine; oral
2.1
7.7
82
405
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
4.3
7.7
27
65
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
2.0
7.6
98
519
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
6.8
7.6
18
27
Z98.0
ICD-10 Finland
Intestinal bypass and anastomosis status
25.3
7.6
10
*
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
10.2
7.5
14
14
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
3.1
7.5
40
135
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.1
7.5
40
135
M54.5
ICD-10 Finland
Low back pain
1.6
7.5
236
1660
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.7
7.5
182
1197
K59.09
ICD-10 Finland
Constipation, unspecified
2.5
7.5
56
232
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
3.0
7.5
43
151
Z71.9
ICD-10 Finland
Counselling, unspecified
2.5
7.5
58
244
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.5
7.5
341
2627
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
80.8
7.4
8
*
C18.00
ICD-10 Finland
Malignant tumor of the caecum without histology
80.8
7.4
8
*
JA3BT
NOMESCO Finland
Cathetrisation of abdominal cavity with X-ray guidance
80.8
7.4
8
*
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
2.9
7.4
43
154
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
3.5
7.4
32
93
A03FA02
ATC
cisapride; oral, rectal
2.1
7.3
78
385
UKC02
NOMESCO Finland
Cystoscopy
1.9
7.3
118
683
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
6.9
7.3
17
25
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
6.9
7.3
17
25
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.0
7.3
90
471
R03BB04
ATC
tiotropium bromide; inhalant
2.1
7.3
84
428
D37.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Stomach
9.5
7.3
14
15
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
7.3
7
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
7.3
7
*
8140/3-C18.2
ICD-O-3
Adenocarcinoma, NOS, of ascending colon
+∞
7.3
7
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
7.3
7
*
CBB50
NOMESCO Finland
Excision of lesion of eyelid and reconstruction using graft or flap
+∞
7.3
7
*
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
7.3
7
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
7.3
7
*
8140/3-C17.0
ICD-O-3
Adenocarcinoma, NOS, of duodenum
+∞
7.3
7
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
7.3
7
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
7.3
7
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
7.3
7
*
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
+∞
7.3
7
*
JDH00
NOMESCO Finland
Duodenotomy
+∞
7.3
7
*
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.6
7.3
195
1316
C03DA01
ATC
spironolactone; oral
2.0
7.3
99
537
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
2.9
7.2
42
150
Z50.1
ICD-10 Finland
Other physical therapy
2.5
7.2
53
218
K59.0
ICD-10 Finland
Constipation
2.5
7.2
54
226
JFH30
NOMESCO Finland
Total colectomy, mucosal proctectomy and ileoanal anastomosis without ileostomy
30.3
7.2
9
*
Z26.9
ICD-10 Finland
Need for immunization against unspecified infectious disease
5.1
7.1
21
42
JF1CG
NOMESCO Finland
Extensive MRI of small bowel
20.2
7.1
10
5
A41.9
ICD-10 Finland
Sepsis, unspecified
3.4
7.1
33
101
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.8
7.1
133
809
L17
ICPC
Foot/toe symptom/complaint
1.6
7.1
197
1344
K85.8
ICD-10 Finland
Other acute pancreatitis
8.9
7.1
14
16
E0000UV
ATC
NA
1.5
7.1
270
1989
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.7
7.0
174
1149
A01
ICPC
Pain general/multiple sites
2.2
7.0
66
308
UJH02
NOMESCO Finland
Anoscopy
2.9
7.0
41
148
J45.0
ICD-10 Finland
Predominantly allergic asthma
2.2
7.0
66
309
SPAT1260
SPAT
Consultation of another employee
1.7
7.0
147
927
J01FA06
ATC
roxithromycin; oral
1.5
7.0
294
2215
UJG02
NOMESCO Finland
Proctoscopy
4.7
6.9
22
48
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.4
6.9
57
247
K29.4
ICD-10 Finland
Chronic atrophic gastritis
3.4
6.9
31
93
R03DA04
ATC
theophylline; systemic, rectal
2.7
6.9
44
167
SPAT1285
SPAT
Provision of consultation response
2.4
6.9
55
238
R10.0
ICD-10 Finland
Acute abdomen
3.3
6.9
32
99
K22.7
ICD-10 Finland
Barrett oesophagus
5.1
6.8
20
40
J45.8
ICD-10 Finland
Mixed asthma
3.4
6.8
31
94
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
11.1
6.8
12
11
A79
ICPC
Malignancy NOS
40.4
6.8
8
*
XFE00
NOMESCO Finland
Epicardial ultrasonography
3.2
6.7
33
106
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.9
6.7
95
523
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.6
6.7
204
1419
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.9
6.7
102
577
R03DC03
ATC
montelukast; oral
1.8
6.7
114
673
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.2
6.6
64
303
R03BA05
ATC
fluticasone; inhalant
1.7
6.6
134
834
Z48.0
ICD-10 Finland
Attention to surgical dressings and sutures
3.1
6.6
34
114
R60.0
ICD-10 Finland
Localized oedema
1.9
6.5
92
507
N02AJ06
ATC
codeine and paracetamol; systemic
1.5
6.5
262
1946
Z09.8
ICD-10 Finland
Follow-up examination after other treatment for other conditions
3.4
6.5
29
87
JKA20
NOMESCO Finland
Cholecystectomy
3.3
6.4
30
93
J45
ICD-10 Finland
Asthma
2.0
6.4
80
422
JFA25
NOMESCO Finland
Endoscopic contact coagulation in small intestine
70.4
6.4
7
*
JDE00
NOMESCO Finland
Gastrojejunostomy
70.4
6.4
7
*
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
70.4
6.4
7
*
103
Kela drug reimbursment
Diabetes, insulin-treated
1.6
6.4
223
1599
K42.9
ICD-10 Finland
Umbilical hernia without obstruction or gangrene
2.6
6.4
43
170
J02AC01
ATC
fluconazole; systemic
1.5
6.4
249
1836
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.6
6.4
45
182
K26.3
ICD-10 Finland
Duodenal ulcer, acute without haemorrhage or perforation
8.2
6.3
13
16
Z80.3
ICD-10 Finland
Family history of malignant neoplasm of breast
8.2
6.3
13
16
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.9
6.3
101
580
K29.0
ICD-10 Finland
Acute haemorrhagic gastritis
6.0
6.3
16
27
RD210
NOMESCO Finland
NA
5.6
6.3
17
31
K22.9
ICD-10 Finland
Disease of oesophagus, unspecified
11.1
6.3
11
10
WZC30
SPAT
NA
3.4
6.3
28
84
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.0
6.3
78
408
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
2.6
6.3
44
176
R63.8
ICD-10 Finland
Other symptoms and signs concerning food and fluid intake
18.2
6.3
9
5
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
18.2
6.3
9
5
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.2
6.3
61
290
N30.0
ICD-10 Finland
Acute cystitis
1.8
6.3
102
590
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
+∞
6.3
6
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
6.3
6
*
JKC50
NOMESCO Finland
Excision of papilla of Vater and anastomosis of bile duct to duodenum or jejunum
+∞
6.3
6
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
6.3
6
*
8240/3-C17.0
ICD-O-3
Neuroendocrine tumor, NOS, of duodenum
+∞
6.3
6
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
6.3
6
*
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
6.3
6
*
C24.1
ICD-10 Finland
Malignant neoplasm: Ampulla of Vater
+∞
6.3
6
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
6.3
6
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
6.3
6
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
6.3
6
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
6.3
6
*
HAE10
NOMESCO Finland
Reconstruction of breast using graft or flap
+∞
6.3
6
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
6.3
6
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
6.3
6
*
8097/3-C44.9
ICD-O-3
Basal cell carcinoma, nodular of skin, NOS
+∞
6.3
6
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
6.3
6
*
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
+∞
6.3
6
*
C50
ICD-10 Finland
Malignant neoplasm of breast
+∞
6.3
6
*
8263/2-C17.0
ICD-O-3
Adenocarcinoma in situ in tubulovillous adenoma of duodenum
+∞
6.3
6
*
8720/3-C44.5
ICD-O-3
Malignant melanoma, NOS, of skin of trunk
+∞
6.3
6
*
C18.72
ICD-10 Finland
Malignant tumor of sigmoid carcinoma of adenoma
+∞
6.3
6
*
C34.9
ICD-10 Finland
Malignant neoplasm: Bronchus or lung, unspecified
+∞
6.3
6
*
JDA55
NOMESCO Finland
Endoscopic dilatation of stomach, pylorus or anastomosis of stomach
26.9
6.2
8
*
R18
ICD-10 Finland
Ascites
7.1
6.2
14
20
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.7
6.2
40
152
D23.1
ICD-10 Finland
Benign neoplasm: Skin of eyelid, including canthus
3.2
6.2
30
96
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.5
6.2
330
2601
NE1AA
NOMESCO Finland
Pelvis X-ray examination
2.2
6.1
62
297
ZXA05
NOMESCO Finland
Left side
1.6
6.1
193
1351
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
3.7
6.1
25
70
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.6
6.1
182
1259
K55.8
ICD-10 Finland
Other vascular disorders of intestine
12.6
6.1
10
8
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
12.6
6.1
10
8
H02AB07
ATC
prednisone; oral
1.8
6.1
111
669
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
8.7
6.1
12
14
K86.1
ICD-10 Finland
Other chronic pancreatitis
6.8
6.1
14
21
K29.6
ICD-10 Finland
Other gastritis
5.2
6.0
17
33
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
5.2
6.0
17
33
R01BA51
ATC
phenylpropanolamine, combinations; oral
2.0
6.0
77
411
TKC20
NOMESCO Finland
Catheterisation of bladder
2.2
6.0
59
280
N06AB04
ATC
citalopram; systemic
1.6
6.0
160
1073
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
2.2
6.0
59
281
B82
ICPC
Anaemia other/unspecified
3.4
6.0
27
82
B03XA02
ATC
darbepoetin alfa; parenteral
4.6
6.0
19
42

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40768797) Stomach Pathology biopsy report
426
973
7.76
198.04
2.4
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
236
378
8.25
149.36
3.5
1.5
ug/l
8.7
3.7
0.52
191
289
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
126
138
10.54
106.95
3.1
1.9
u/ml
28.3
97.3
0.61
101
110
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
223
533
5.31
90.80
3.0
1.9
g/l
0.2
0.2
1.91
210
484
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
629
3342
4.37
83.55
9.6
3.8
umol/l
13.0
12.0
0.40
613
3134
(3024561) Albumin [Mass/volume] in Serum or Plasma
570
2935
3.85
76.73
8.5
3.8
g/l
34.3
35.4
4.96
543
2704
(3032080) INR in Blood by Coagulation assay
550
2973
3.40
64.12
12.8
10.4
inr
1.3
1.3
0.66
119
821
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
399
1801
3.29
62.82
3.3
2.3
mg/l
3.8
3.0
4.03
354
1524
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
73
78
10.14
62.41
2.9
1.8
u/ml
438.7
66.6
0.50
61
71
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
193
551
4.24
61.13
3.9
2.1
u/l
58.1
43.6
0.35
179
450
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
215
668
3.97
60.51
4.8
2.3
umol/l
9.4
7.4
0.36
193
580
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
438
2187
3.06
56.29
4.8
2.2
u/l
55.9
57.6
0.38
421
2007
(3044640) Blood type and Crossmatch panel - Blood
404
1945
3.05
55.16
4.2
2.1
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
97
172
6.24
53.49
1.6
1.4
ug/g
208.9
305.5
4.40
71
108
(4035726)
102
190
5.96
53.47
1.3
1.2
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
520
2961
2.94
50.79
7.1
3.6
—
—
—
0
0
(3022145) Colonoscopy Study observation
199
661
3.62
49.97
1.5
1.3
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
243
924
3.28
49.12
3.8
2.5
%
19.2
23.2
3.50
207
781
(3013650) Neutrophils [#/volume] in Blood by Automated count
589
3633
3.01
48.72
10.6
6.2
e9/l
4.5
4.3
0.96
538
3128
(3022948) Iron [Moles/volume] in Serum or Plasma
269
1096
3.13
48.25
3.7
2.4
umol/l
10.9
13.1
5.35
253
1006
(40768804) Tissue Pathology biopsy report
409
2098
2.83
47.93
2.6
1.7
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
643
4185
3.19
47.79
7.7
4.4
mmol/l
6.8
6.8
0.01
612
3928
(3004789) Transferrin [Mass/volume] in Serum or Plasma
252
994
3.18
47.73
3.8
2.4
g/l
2.3
2.3
0.29
233
924
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
736
5253
3.95
45.62
12.6
5.4
u/l
89.5
76.2
3.50
716
4825
(3023368) Bacteria identified in Blood by Culture
371
1846
2.79
45.57
6.0
4.0
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
562
3508
2.77
43.09
9.7
5.6
mmol/l
1.2
1.2
2.71
500
2972
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
387
2022
2.67
42.43
5.0
2.6
u/l
32.2
34.5
0.66
370
1931
(3019198) Lymphocytes [#/volume] in Blood
543
3348
2.71
42.39
7.5
5.4
e9/l
1.7
1.8
2.07
494
2918
(3001604) Monocytes [#/volume] in Blood
534
3271
2.69
42.15
7.4
5.4
e9/l
0.6
0.6
0.02
479
2802
(3006315) Basophils [#/volume] in Blood
535
3289
2.68
41.76
7.5
5.4
e9/l
0.0
0.0
0.17
480
2824
(3013115) Eosinophils [#/volume] in Blood
546
3413
2.67
40.81
7.8
5.5
e9/l
0.2
0.2
0.13
495
2962
(3027945) Reticulocytes/100 erythrocytes in Blood
216
875
2.97
38.09
2.7
2.2
%
1.9
1.8
0.77
199
774
(3001122) Ferritin [Mass/volume] in Serum or Plasma
469
2806
2.49
37.18
4.9
2.7
ug/l
105.0
131.8
2.04
430
2537
(40758558) Short blood count panel - Blood
306
1506
2.61
36.83
8.1
4.8
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
322
1625
2.58
36.77
6.9
3.4
%
84.7
86.6
0.62
315
1578
(3019069) Monocytes/100 leukocytes in Blood
496
3056
2.49
36.69
7.8
5.9
%
8.7
8.7
0.06
468
2832
(3012095) Magnesium [Moles/volume] in Serum or Plasma
234
1008
2.82
36.67
4.0
2.6
mmol/l
0.8
0.8
0.75
217
925
(3002030) Lymphocytes/100 leukocytes in Blood
502
3111
2.49
36.65
7.7
5.8
%
25.4
27.1
3.24
471
2868
(3018010) Neutrophils/100 leukocytes in Blood
498
3082
2.48
36.36
7.4
5.5
%
59.2
57.8
1.93
466
2858
(3006504) Eosinophils/100 leukocytes in Blood
492
3042
2.46
35.79
7.5
5.6
%
3.0
3.0
0.08
460
2804
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
114
323
3.92
35.52
1.8
1.7
g/l
1.6
1.5
0.21
96
281
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
426
2481
2.43
35.26
4.6
3.1
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
141
464
3.44
35.14
2.1
1.5
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
300
1506
2.53
34.19
4.3
2.1
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
178
690
3.00
33.61
4.3
2.9
u/l
229.6
241.1
0.96
167
649
(3022096) Basophils/100 leukocytes in Blood
475
2950
2.38
33.36
7.4
5.6
%
0.7
0.7
0.01
446
2724
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
497
3173
2.36
32.39
9.5
5.1
mmol/l
1.2
1.2
3.49
467
2792
(3042936) Bacteria identified in Isolate by Culture
216
957
2.68
31.52
2.6
2.0
—
—
—
0
0
(3018418) pH of Serum or Plasma
356
2003
2.34
30.78
6.2
3.2
ph
7.4
7.4
0.81
51
337
(36304419) Bacteria [Presence] in Urine
331
1808
2.36
30.63
4.3
3.0
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
342
1895
2.34
30.61
4.3
3.0
e6/l
0.8
0.4
0.70
287
1440
(3003458) Phosphate [Moles/volume] in Serum or Plasma
207
926
2.63
29.42
7.0
4.8
mmol/l
1.0
1.0
0.55
190
840
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
192
831
2.69
29.13
8.3
6.3
kpa
5.1
5.1
0.13
183
794
(3027801) Oxygen [Partial pressure] in Arterial blood
192
831
2.69
29.13
8.3
6.3
kpa
11.6
11.3
0.29
183
794
(3000850) Epithelial cells [#/volume] in Urine
280
1450
2.39
28.98
3.2
2.4
e6/l
4.3
5.3
1.21
244
1255
(3003396) Base excess in Arterial blood by calculation
191
827
2.69
28.94
8.2
6.3
mmol/l
1.1
1.3
0.37
157
635
(3002256) Pathology report gross observation
133
474
3.14
28.82
1.4
1.1
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
372
2185
2.25
28.47
7.2
5.6
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
162
653
2.83
28.13
2.5
2.5
e9/l
73.0
69.1
0.46
122
517
(3002582) Erythrocytes [#/volume] in Urine
355
2055
2.25
28.06
4.4
3.1
e6/l
28.6
105.0
1.59
302
1592
(3015377) Calcium [Moles/volume] in Serum or Plasma
380
2268
2.22
27.78
3.1
2.1
mmol/l
2.3
2.4
2.10
339
1860
(3020779) Urea [Moles/volume] in Serum or Plasma
149
579
2.91
27.66
8.9
6.5
mmol/l
10.2
10.6
0.30
144
544
(3018095) Leukocytes [#/volume] in Urine
396
2415
2.20
27.29
5.0
3.6
e6/l
35.1
103.7
4.34
316
1715
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
235
1171
2.39
26.15
3.2
2.7
e6/l
2.6
1.3
0.44
152
690
(3026782) Osmolality of Urine
258
1340
2.33
26.10
3.4
2.6
mosm/kgh2o
510.9
543.9
1.51
221
1126
(3002173) Hemoglobin [Mass/volume] in Arterial blood
162
680
2.71
25.87
9.2
6.9
g/l
116.9
121.7
2.11
156
654
(3000991) Gas panel - Venous blood
146
582
2.82
25.75
8.5
6.6
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
168
722
2.65
25.59
4.8
3.2
mmol/l
1.6
2.0
0.82
143
575
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
481
3242
2.11
24.74
2.6
2.0
pmol/l
90.8
94.9
1.18
284
1633
(3013707) Erythrocyte sedimentation rate by Westergren method
681
5289
2.43
24.13
5.5
4.3
mm/h
15.8
12.5
4.95
635
4851
(3048689) Calprotectin [Mass/mass] in Stool
163
714
2.59
23.76
1.8
2.3
ug/g
149.2
165.3
0.27
135
562
(3005719) IgG [Mass/volume] in Serum or Plasma
122
463
2.91
23.47
2.2
2.2
g/l
10.3
10.9
0.72
114
424
(3021589) Normoblasts [#/volume] in Blood
443
2943
2.05
23.14
13.1
8.6
e9/l
0.0
0.0
0.55
381
2408
(3019309) Folate [Moles/volume] in Red Blood Cells
278
1570
2.14
22.33
1.8
1.8
nmol/l
1248.4
1184.7
0.49
221
1176
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
85
276
3.31
21.31
2.5
1.7
ug/l
3.7
1.6
0.86
74
245
(3007853) Bacteria identified in Skin by Aerobe culture
168
784
2.42
21.22
2.2
1.7
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
206
1069
2.22
20.22
3.6
2.9
e6/l
2.9
2.6
0.19
127
591
(3019060) Gas panel - Arterial blood
121
495
2.68
20.07
7.4
4.8
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
101
376
2.91
20.02
1.7
1.3
g/l
1.3
1.1
0.55
95
343
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
169
811
2.35
19.95
2.4
1.7
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
169
814
2.34
19.77
2.5
1.8
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
347
2207
1.97
19.55
3.7
3.4
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
135
597
2.50
19.04
2.5
1.6
g/l
65.6
67.1
1.42
124
534
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
255
1469
2.05
18.91
5.5
4.1
ng/l
129.6
445.4
3.63
214
1213
(3037467) Urinalysis macro (dipstick) panel - Urine
621
4848
2.04
18.60
5.5
4.4
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
212
1146
2.13
18.60
2.4
1.8
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
309
1917
1.96
18.49
1.8
1.5
nmol/l
22.1
21.0
0.26
271
1595
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
562
4246
1.95
18.42
5.1
3.0
u/l
75.1
48.1
4.14
525
3888
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
792
6891
3.12
17.47
31.0
13.3
mg/l
26.1
23.8
1.25
705
5374
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
418
2916
1.85
17.05
2.9
2.3
nmol/l
76.0
78.9
1.27
377
2546
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
366
2452
1.86
16.97
3.6
3.0
ng/l
2021.1
1415.9
0.84
318
2093
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
40
89
4.67
16.97
1.3
1.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
123
555
2.42
16.51
1.8
1.5
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
88
340
2.77
16.21
5.3
3.5
mmol/l
23.6
24.4
1.54
82
294
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
244
1453
1.95
16.08
2.0
1.6
mg/l
1.3
1.2
0.07
191
1123
(3007164) IgA [Mass/volume] in Serum or Plasma
209
1181
2.02
16.00
1.5
1.3
g/l
2.7
2.7
0.09
128
707
(3008152) Bicarbonate [Moles/volume] in Arterial blood
111
485
2.48
15.96
11.3
6.7
mmol/l
24.0
24.6
0.62
106
451
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
127
591
2.35
15.88
1.8
1.4
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
40
94
4.42
15.87
1.5
1.9
g/l
0.9
0.9
0.01
29
75
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
227
1329
1.97
15.66
3.2
2.2
mmol/l
2.5
2.4
1.33
203
1145
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
91
366
2.66
15.50
9.8
8.8
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
467
3451
1.78
15.03
4.7
3.8
estimate
0.0
0.0
0.00
66
592
(3037522) Nuclear Ab [Titer] in Serum
171
920
2.07
14.87
1.4
1.3
titre
401.8
599.3
1.16
44
215
(3021601) Nitrite [Presence] in Urine by Test strip
467
3466
1.77
14.67
6.7
5.1
estimate
0.0
0.0
0.00
67
590
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
90
372
2.59
14.50
3.8
2.4
%
0.7
0.7
0.26
90
356
(3009261) Glucose [Presence] in Urine by Test strip
469
3506
1.75
14.17
4.9
3.8
estimate
0.0
0.0
0.50
66
588
(3025941) Bacteria identified in Stool by Culture
82
331
2.63
13.85
1.4
1.3
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
406
2929
1.74
13.79
5.2
4.0
ng/l
48.0
54.1
0.11
316
2163
(3023183) Ammonium ion [Moles/volume] in Plasma
48
143
3.50
13.74
5.3
2.5
umol/l
36.3
34.7
0.13
41
124
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
139
711
2.14
13.73
3.8
3.2
ng/l
230.1
204.5
0.24
127
660
(3026493) Urate [Moles/volume] in Serum or Plasma
286
1875
1.79
13.52
3.5
2.4
umol/l
363.8
7641.2
7.46
251
1590
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
59
202
3.06
13.51
3.4
2.5
u/ml
0.3
0.4
0.36
39
119
(3022217) INR in Platelet poor plasma by Coagulation assay
184
1050
1.96
13.46
34.6
29.0
inr
1.3
1.3
0.19
13
150
(40760892) CBC W Ordered Manual Differential panel - Blood
226
1387
1.86
13.22
5.0
4.2
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
345
2400
1.74
13.19
2.3
2.2
u/l
257.0
245.9
0.05
327
2248
(3004588) Protein electrophoresis panel - Serum or Plasma
111
527
2.27
13.16
2.1
1.5
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
84
355
2.52
12.91
7.7
7.7
mmol/l
24.3
24.4
0.17
77
324
(3044889) 12 lead EKG panel
622
5121
1.79
12.65
5.3
4.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
644
5368
1.82
12.43
4.8
3.8
pmol/l
15.0
15.0
0.23
591
4822
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
37
99
3.86
12.39
5.2
6.1
iu/ml
90.4
418.3
—
7
14
(3014765) Yersinia sp identified in Stool by Organism specific culture
56
196
2.99
12.35
1.3
1.1
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
61
226
2.83
12.14
2.7
1.4
mg/l
37.9
35.4
0.10
53
181
(3034860) Kappa light chains.free [Mass/volume] in Serum
61
226
2.83
12.14
2.7
1.4
mg/l
126.7
45.3
0.63
52
181
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
45
140
3.34
12.06
1.4
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
45
140
3.34
12.06
1.4
1.4
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
15
17
8.96
12.03
3.7
2.4
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
56
199
2.94
12.02
1.3
1.1
—
—
—
0
0
(3020891) Body temperature
76
317
2.53
12.00
9.0
4.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
93
427
2.32
11.90
1.9
1.5
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
55
195
2.95
11.86
1.3
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
76
320
2.51
11.76
1.5
1.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
69
279
2.60
11.61
1.4
1.3
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
49
167
3.05
11.32
2.2
1.3
—
—
—
0
0
(44790049)
27
61
4.54
11.26
1.9
1.5
—
—
—
0
0
(44790048)
27
61
4.54
11.26
1.9
1.5
—
—
—
0
0
(44790047)
27
61
4.54
11.26
1.9
1.5
—
—
—
0
0
(44806118)
27
61
4.54
11.26
1.9
1.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
41
126
3.37
11.21
1.7
1.5
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
129
694
2.01
11.03
1.9
1.6
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
68
280
2.55
11.03
7.0
4.0
mmol/l
1.6
1.4
0.40
68
273
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
84
384
2.32
10.85
4.4
3.6
%
47.8
48.8
0.14
84
377
(3013139) Helicobacter pylori Ag [Presence] in Stool
94
452
2.21
10.77
1.2
1.3
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
33
91
3.73
10.61
1.3
1.4
u/ml
130.5
113.6
—
11
8
(3002385) Erythrocyte distribution width [Ratio]
655
5581
1.75
10.59
36.6
15.9
%
14.4
13.7
18.71
649
5438
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
39
121
3.33
10.52
1.7
1.5
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
58
228
2.66
10.33
1.6
1.6
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
84
399
2.23
9.91
2.8
2.4
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
134
757
1.91
9.90
3.1
2.5
ug/l
5.5
7.7
1.33
120
657
(3010370) Gastrin [Moles/volume] in Serum or Plasma
13
5
26.36
9.83
1.8
1.2
pmol/l
59.3
34.6
—
13
5
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
212
1380
1.71
9.78
1.3
1.2
u/ml
3.1
2.0
0.18
51
386
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
53
207
2.66
9.57
1.5
1.2
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
114
617
1.98
9.54
2.5
1.8
nmol/l
318.9
362.2
1.50
101
561
(3036489) Thrombin time
55
221
2.59
9.39
2.1
1.8
s
22.3
21.2
0.79
50
192
(3027273) Bicarbonate [Moles/volume] in Venous blood
84
408
2.17
9.38
4.1
2.9
mmol/l
24.8
25.2
0.51
84
394
(3019550) Sodium [Moles/volume] in Serum or Plasma
800
7354
2.44
9.31
36.0
16.3
mmol/l
139.2
139.7
6.58
788
7156
(3012516) Albumin [Mass/volume] in Urine
334
2467
1.58
9.22
3.2
3.3
mg/l
1037.5
180.4
1.38
226
1549
(3023103) Potassium [Moles/volume] in Serum or Plasma
801
7375
2.44
9.15
36.0
16.4
mmol/l
4.0
4.0
1.13
787
7167
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
112
612
1.96
9.10
5.3
3.7
ng/l
115.3
91.2
1.55
92
533
(4010399)
106
569
1.99
9.07
1.6
1.5
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
246
1694
1.64
9.06
4.6
3.8
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
30
87
3.54
8.99
1.8
1.6
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
33
102
3.33
8.97
1.2
1.3
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
46
173
2.75
8.94
1.5
1.6
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
105
573
1.95
8.56
2.8
2.4
ml/min/173m2
51.1
63.8
2.77
52
233
(3028192) IgG subclass 2 [Mass/volume] in Serum
24
62
3.95
8.46
1.2
1.5
g/l
2.9
2.6
0.29
17
47
(3024139) IgG subclass 3 [Mass/volume] in Serum
24
62
3.95
8.46
1.2
1.5
g/l
0.5
0.4
0.61
17
47
(3027135) IgG subclass 1 [Mass/volume] in Serum
24
62
3.95
8.46
1.2
1.5
g/l
7.1
7.1
0.01
17
47
(40761535) Cells panel - Urine sediment
114
645
1.89
8.34
4.6
3.5
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
40
145
2.85
8.33
1.4
1.3
—
—
—
0
0
(4062490)
24
63
3.89
8.29
1.2
1.5
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
37
130
2.93
8.15
1.7
1.6
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
18
38
4.82
8.14
1.2
1.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
233
1625
1.60
8.00
5.7
4.2
kg/l
1.0
1.0
2.55
55
233
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
18
39
4.69
7.90
1.8
1.3
ug/l
30.5
15.7
0.66
18
39
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
14
24
5.91
7.87
2.3
1.9
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
14
24
5.91
7.87
2.1
1.4
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
181
1191
1.66
7.84
1.3
1.3
iu/ml
41.4
43.6
0.06
57
388
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
134
812
1.77
7.83
1.6
1.4
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
64
300
2.23
7.81
2.6
1.4
g/l
4.0
3.8
0.17
41
209
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
64
300
2.23
7.81
2.6
1.4
g/l
7.5
7.6
0.13
44
215
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
44
174
2.61
7.78
2.0
1.6
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
119
698
1.82
7.75
4.3
3.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
39
148
2.71
7.48
1.3
1.2
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
63
300
2.19
7.40
2.7
1.4
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
60
281
2.22
7.34
2.6
1.4
g/l
9.7
10.4
0.43
48
234
(21494890) Protein electrophoresis panel - 24 hour Urine
22
60
3.74
7.22
2.5
1.1
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
17
38
4.54
7.20
1.0
1.0
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
339
2618
1.49
7.15
3.9
4.0
mg/mmol
22.0
7.8
2.42
221
1649
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
345
2681
1.48
7.02
5.5
4.0
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
35
130
2.76
7.00
1.1
1.2
—
—
—
0
0
(40768441) Liver Pathology biopsy report
15
31
4.91
6.95
1.6
1.4
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
53
243
2.26
6.84
2.7
1.4
g/l
0.7
0.4
0.43
43
206
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
30
104
2.95
6.80
1.4
1.3
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
11
17
6.54
6.79
2.9
4.5
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
10
14
7.22
6.71
3.6
1.8
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
83
455
1.91
6.67
1.8
1.6
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
57
275
2.15
6.51
2.8
1.4
g/l
3.2
3.1
0.49
41
212
(3024471) HLA-A [Type]
11
18
6.18
6.44
1.0
1.0
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
715
6494
1.63
6.34
6.1
4.7
mu/l
1.9
2.2
0.65
664
5851
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
171
1165
1.59
6.33
1.3
1.3
u/ml
38.6
12.9
0.45
60
441
(40761511) CBC panel - Blood by Automated count
774
7182
1.85
6.33
30.6
13.1
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
65
334
2.02
6.30
3.0
2.9
pmol/l
4.2
4.5
2.20
57
286
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
14
30
4.73
6.23
2.2
1.7
%
16.2
10.6
—
9
14
(3052851) Hemolysis interference index of Serum or Plasma
46
207
2.29
6.22
3.7
3.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
28
99
2.89
6.15
1.1
1.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
324
2536
1.45
6.14
3.1
3.2
mmol/l
7.3
7.4
0.07
264
2122
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
49
228
2.22
6.12
2.6
3.0
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
25
84
3.04
6.00
1.1
1.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
677
6096
1.54
5.97
34.5
14.6
%
37.7
39.5
4.07
416
3946
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
48
225
2.20
5.90
2.8
2.4
ug/min
214.2
87.7
0.57
36
134
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
20
59
3.45
5.89
1.2
1.2
u/l
56.9
50.9
0.30
14
39
(3000494) Fungus identified in Specimen by Culture
125
803
1.65
5.86
1.9
1.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
25
86
2.96
5.77
1.6
1.5
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
21
65
3.29
5.75
3.0
1.6
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
89
526
1.77
5.65
4.5
3.9
%
1.6
0.8
0.39
23
112
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
431
3588
1.41
5.65
2.9
2.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
28
104
2.75
5.64
1.5
1.3
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
18
51
3.58
5.63
2.2
1.6
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
20
61
3.33
5.61
1.5
1.3
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
22
72
3.11
5.52
1.5
1.4
e6/l
1515.9
2094.3
0.46
17
52
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
791
7442
1.88
5.42
17.9
9.3
u/l
26.8
25.5
1.30
775
7104
(3024932) HLA-DR beta [Type]
10
18
5.61
5.33
1.1
1.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
231
1734
1.46
5.33
1.9
1.8
pmol/l
464.4
22798729.0
1.51
204
1408
(3028308) Erythrocytes [#/volume] in Pleural fluid
20
64
3.18
5.21
1.4
1.5
e6/l
154261.6
136394.0
0.05
13
37
(40768793) Breast Pathology biopsy report
17
49
3.52
5.19
1.2
1.1
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
28
109
2.62
5.18
2.2
2.4
mmol/l
105.3
105.6
0.08
28
109
(3041354) Potassium [Moles/volume] in Venous blood
28
109
2.62
5.18
2.2
2.4
mmol/l
4.2
4.1
0.76
28
109
(3039162) Centromere protein B Ab [Units/volume] in Serum
24
86
2.84
5.18
1.3
1.3
u/ml
89.7
62.8
—
5
6
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
22
75
2.98
5.17
1.7
1.5
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
48
238
2.08
5.15
2.9
1.4
g/l
36.5
37.7
0.67
40
195
(40768443) Skin Pathology biopsy report
50
252
2.05
5.14
1.2
1.2
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
8
6
13.44
5.08
7.8
1.3
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
25
93
2.74
5.04
1.1
1.2
u/ml
312.6
255.1
0.46
16
54
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
73
421
1.80
5.04
1.2
1.3
—
45.0
—
0
17
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
103
655
1.65
5.02
2.1
1.7
%
1.8
1.5
1.52
86
552
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
30
123
2.49
5.01
1.5
1.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
55
290
1.96
5.00
1.0
1.0
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
27
106
2.60
4.92
2.2
2.5
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
89
548
1.70
4.90
3.6
2.8
mmol/l
1.2
1.2
0.02
82
462
(3003694) ABO and Rh group [Type] in Blood
214
1607
1.44
4.88
1.5
1.3
—
—
—
0
0
(4094501)
44
216
2.09
4.86
1.1
1.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
26
101
2.62
4.84
1.1
1.2
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
15
42
3.62
4.78
1.1
1.2
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
55
295
1.92
4.76
1.6
2.0
u/l
36.6
39.2
0.40
43
255
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
15
43
3.53
4.63
2.3
2.3
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
23
86
2.72
4.61
1.4
1.2
u/ml
2.0
2.8
—
9
25
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
19
64
3.01
4.58
2.2
2.3
—
—
—
0
0
(3000492) Spirometry study
91
577
1.65
4.49
1.6
1.5
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
12
30
4.04
4.45
2.0
1.3
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
18
60
3.04
4.42
1.3
1.4
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
144
1028
1.48
4.22
16.2
6.9
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
13
36
3.65
4.21
2.5
2.4
u/ml
582.5
1202.7
1.01
13
36
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
21
79
2.70
4.18
1.5
1.4
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
80
501
1.66
4.15
4.7
4.0
%
0.3
0.1
0.39
21
97
(3047181) Lactate [Moles/volume] in Blood
44
230
1.96
4.13
10.0
6.0
mmol/l
1.6
1.3
0.78
38
207
(3038515) Glucose [Moles/volume] in Venous blood
37
182
2.08
4.10
2.9
3.2
mmol/l
8.2
7.7
0.43
37
176
(3029937) Albumin [Presence] in Urine by Test strip
239
1882
1.38
4.06
5.4
4.0
estimate
0.0
0.0
0.69
64
580
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
11
28
3.97
3.98
1.3
1.1
u/l
23.6
21.4
0.09
11
23
(36660697) Celiac disease serology panel - Serum
78
492
1.64
3.95
1.2
1.2
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
15
48
3.16
3.94
1.5
1.4
—
—
—
0
0
(4281824)
12
33
3.67
3.93
1.7
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
24
100
2.44
3.92
1.0
1.1
—
—
—
0
0
(3017704) Immunofixation for Urine
14
43
3.29
3.92
2.3
1.2
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
10
24
4.20
3.89
1.0
1.1
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
38
193
2.01
3.88
2.9
3.1
mmol/l
1.6
1.6
0.14
38
188
(3002179) Metamyelocytes/100 leukocytes in Blood
76
480
1.64
3.83
4.1
3.9
%
0.6
0.5
0.10
14
85
(3041096) Erythrocytes [Presence] in Urine by Automated
228
1797
1.37
3.82
4.6
3.4
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
18
66
2.76
3.77
5.5
3.6
%
0.8
1.1
0.36
13
52
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
13
39
3.37
3.77
1.5
1.4
u/l
5.6
12.1
—
7
15
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
6
5
12.07
3.77
2.0
2.0
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
22
90
2.48
3.74
1.5
1.3
—
—
—
0
0
(3013512) EKG study
281
2296
1.33
3.70
4.8
4.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
40
211
1.94
3.69
5.1
4.8
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
16
56
2.89
3.64
1.6
1.6
—
—
—
0
0
(44813793)
13
40
3.28
3.63
1.2
1.0
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
36
184
2.00
3.63
1.7
1.6
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
10
26
3.88
3.53
1.0
1.3
u/l
260.8
206.5
—
10
26
(21494755) Public health laboratory ask at order entry panel
18
418
0.42
3.51
1.4
1.4
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
801
7681
1.72
3.50
46.6
19.7
e9/l
249.6
245.2
0.92
787
7448
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
31
152
2.08
3.50
1.2
1.1
—
—
—
0
0
(3024731) MCV [Entitic volume]
801
7682
1.71
3.49
46.3
19.6
fl
91.0
91.5
1.51
794
7546
(3035941) MCH [Entitic mass]
801
7682
1.71
3.49
46.3
19.6
pg
30.1
30.4
5.26
794
7546
(3037756) Immunofixation for Serum or Plasma
28
132
2.16
3.49
1.7
1.2
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
15
52
2.92
3.47
1.3
1.3
mmol/l
6.7
7.0
0.19
15
47
(3026361) Erythrocytes [#/volume] in Blood
801
7683
1.71
3.47
46.5
19.7
e12/l
4.3
4.5
11.99
782
7427
(3010813) Leukocytes [#/volume] in Blood
801
7684
1.71
3.46
46.6
19.7
e9/l
7.1
6.7
4.13
783
7429
(3000963) Hemoglobin [Mass/volume] in Blood
801
7686
1.70
3.43
47.0
19.8
g/l
128.5
135.7
25.45
793
7547
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
29
140
2.11
3.41
1.7
1.3
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
20
82
2.47
3.40
1.3
1.2
u/ml
16.6
6.6
—
7
39
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
9
18
5.04
3.37
2.9
1.9
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
74
480
1.59
3.37
4.0
4.1
%
0.0
1.0
0.55
14
90
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
11
32
3.47
3.34
1.3
1.1
u/l
75.5
94.2
0.34
11
27
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
721
6778
1.41
3.31
8.4
6.5
mmol/mol
41.5
40.7
1.18
670
6245
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
30
149
2.05
3.29
1.5
1.4
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
22
96
2.33
3.29
1.0
1.0
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
59
365
1.66
3.25
2.9
2.5
e6/l
0.1
0.2
0.76
59
356
(3000330) Specific gravity of Urine by Test strip
65
413
1.62
3.23
4.6
3.7
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
21
92
2.32
3.12
1.5
1.3
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
26
125
2.11
3.11
3.2
1.9
%
69.6
63.0
0.70
26
125
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
14
50
2.83
3.10
1.4
1.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
68
442
1.59
3.09
2.0
3.0
e9/l
4.1
4.2
0.10
43
317
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
7
12
5.87
3.02
1.6
2.7
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
700
6576
1.36
2.98
24.8
12.3
ml/min/173m2
75.1
75.9
0.44
618
5300
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
22
441
0.49
2.94
2.3
1.8
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
34
185
1.87
2.91
1.3
1.2
u/ml
1.9
2.9
—
6
22
(44816559) Phosphatidylethanol [Mass/volume] in Blood
25
122
2.08
2.89
2.0
1.2
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
6
9
6.70
2.87
1.8
1.6
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
16
65
2.49
2.80
1.3
1.0
u/ml
1.1
4.7
—
7
28
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
10
31
3.25
2.78
1.1
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
10
31
3.25
2.78
1.1
1.0
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
34
189
1.83
2.74
1.3
1.2
u/ml
2.1
9.3
—
6
31
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
19
85
2.26
2.72
1.1
1.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
41
242
1.73
2.72
1.7
2.0
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
15
60
2.53
2.71
1.7
1.4
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
15
60
2.53
2.71
1.5
1.5
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
17
73
2.36
2.66
1.4
1.1
u/ml
1.3
1.8
—
9
31
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
43
259
1.70
2.66
1.6
1.6
—
165.0
—
0
12
(4306422)
19
86
2.24
2.65
1.3
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
18
80
2.28
2.62
4.3
3.3
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
13
50
2.62
2.54
1.5
1.2
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
13
50
2.62
2.54
1.5
1.2
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
13
50
2.62
2.54
1.2
1.3
promille
1.2
1.3
—
7
39
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
13
50
2.62
2.54
1.5
1.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
10
33
3.05
2.53
1.4
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
10
33
3.05
2.53
1.4
1.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
10
33
3.05
2.53
1.3
1.0
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
29
158
1.86
2.50
3.1
2.6
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
22
109
2.05
2.48
4.2
2.7
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
7
16
4.40
2.48
1.1
1.1
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
15
63
2.41
2.47
1.8
1.3
%
14.0
27.8
—
9
36
(3000093) Morphology [Interpretation] in Blood Narrative
16
70
2.31
2.42
1.1
1.2
—
—
—
0
0
(3010421) pH of Blood
31
175
1.80
2.41
6.2
4.3
ph
7.4
7.4
0.79
25
136
(40768800) Prostate Pathology biopsy report
12
46
2.63
2.36
1.2
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
15
65
2.33
2.32
1.1
1.2
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
10
35
2.88
2.31
1.4
2.1
nmol/l
15.9
19.7
—
10
29
(1616796) Gas panel - Central venous blood
25
135
1.88
2.24
4.2
3.9
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
25
135
1.88
2.24
1.6
1.4
mmol/l
62.2
63.7
0.06
18
111
(3018851) Theophylline [Moles/volume] in Serum or Plasma
5
9
5.58
2.21
1.4
1.3
umol/l
52.4
53.1
—
5
9
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
13
54
2.43
2.20
1.8
1.4
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
9
30
3.02
2.15
1.6
1.6
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
16
75
2.16
2.09
1.7
1.2
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
14
62
2.28
2.08
1.4
1.0
u/ml
0.5
0.7
—
6
24
(3051651) Icteric interference index of Serum or Plasma
9
31
2.92
2.07
2.2
2.4
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
7
20
3.52
2.06
6.6
2.4
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
15
69
2.19
2.05
1.3
1.2
nmol/l
1.6
1.5
0.13
15
58
(3025468) Yersinia sp identified in Specimen by Organism specific culture
16
76
2.13
2.03
1.7
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
16
76
2.13
2.03
1.7
1.2
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
65
462
1.44
2.02
3.9
3.9
kpa
5.1
5.2
0.22
59
432
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
14
63
2.24
2.01
1.1
1.2
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
34
210
1.64
1.97
1.4
1.6
iu/ml
0.1
0.1
—
6
44
(3034426) Prothrombin time (PT)
7
21
3.35
1.97
1.1
1.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
12
51
2.37
1.95
1.9
1.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
23
127
1.83
1.95
2.9
2.8
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
31
188
1.67
1.93
3.5
3.5
nmol/l
0.8
0.8
0.23
22
142
(3019832) Treponema pallidum Ab [Presence] in Serum
40
259
1.57
1.93
1.5
1.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
16
78
2.07
1.92
1.6
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
16
78
2.07
1.92
1.7
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
16
78
2.07
1.92
1.7
1.2
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
61
434
1.44
1.89
4.0
3.9
mmol/l
1.5
2.0
0.31
42
326
(3049717) Cytology report of Urine Cyto stain
37
239
1.57
1.81
3.5
1.8
—
—
—
0
0
(3035880) pH of Pleural fluid
9
35
2.59
1.80
1.0
1.3
—
—
—
0
0
(21494434) Karyotype in Bone marrow
13
60
2.18
1.78
1.1
1.2
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
9
36
2.52
1.74
1.4
1.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
9
36
2.52
1.74
1.4
1.4
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
5
13
3.86
1.71
1.2
1.2
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
5
13
3.86
1.71
1.6
1.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
12
55
2.20
1.68
1.2
1.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
16
83
1.95
1.65
1.3
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
95
749
1.30
1.59
1.6
1.5
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
18
311
0.57
1.59
1.7
1.5
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
18
99
1.84
1.58
1.3
1.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
36
241
1.52
1.54
2.9
2.6
g/l
0.5
0.2
0.72
20
77
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
33
2.44
1.54
1.4
1.1
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
5
15
3.35
1.52
4.8
1.8
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
5
15
3.35
1.52
1.6
1.3
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
5
15
3.35
1.52
1.4
1.2
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
16
86
1.88
1.51
1.3
1.2
nmol/l
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
33
218
1.53
1.51
1.6
1.3
—
—
—
0
0
(4268621)
12
58
2.08
1.49
2.0
2.1
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
56
413
1.38
1.47
2.1
2.3
nmol/l
15.9
15.2
0.06
43
361
(3001019) Free T4 and TSH panel - Serum or Plasma
12
228
0.52
1.47
1.8
1.7
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
21
125
1.70
1.44
1.9
1.5
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
22
133
1.67
1.43
1.2
1.6
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
9
39
2.32
1.43
1.2
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
52
382
1.38
1.40
1.3
1.2
iu/ml
86.8
133.0
0.93
20
150
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
16
89
1.81
1.38
1.1
1.1
—
20.6
—
0
5
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
13
68
1.93
1.34
1.2
1.1
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
9
43
2.10
1.30
1.4
1.5
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
8
34
2.37
1.29
1.3
1.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
730
7073
1.22
1.28
5.8
5.0
mmol/l
6.3
6.1
3.07
665
6350
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
11
55
2.01
1.27
1.0
1.0
—
—
—
0
0
(3022313) Gas panel - Capillary blood
46
338
1.38
1.26
4.0
4.0
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
13
70
1.87
1.24
1.6
1.3
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
8
37
2.17
1.21
1.1
1.2
—
—
—
0
0
(3011648) Oxygen content in Venous blood
11
57
1.94
1.17
1.4
1.5
%
14.0
11.0
2.63
11
57
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
7
30
2.34
1.12
1.0
1.0
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
10
51
1.97
1.11
1.3
1.0
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
7
31
2.27
1.10
2.0
2.5
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
7
31
2.27
1.10
1.0
1.0
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
28
193
1.47
1.10
2.3
1.6
e6/l
17991.8
15288.2
0.18
23
143
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
21
2.39
1.09
1.2
1.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
7
32
2.20
1.08
1.6
1.2
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
7
32
2.20
1.08
1.1
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
33
2.13
1.05
1.4
1.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
288
2634
1.14
1.05
5.0
3.9
ug/l
2.0
2.0
0.21
250
2351
(3009214) Lutropin [Units/volume] in Serum or Plasma
17
106
1.62
1.03
1.6
1.3
u/l
16.4
8.8
0.60
11
85
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
7
34
2.07
1.03
1.1
1.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
12
68
1.78
1.01
2.5
2.6
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
16
99
1.63
1.00
2.0
1.5
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
39
292
1.35
0.99
4.3
4.3
mmol/l
24.7
24.9
0.10
33
272
(3039443) Prostate specific Ag panel - Serum or Plasma
7
131
0.53
0.99
1.1
1.7
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
9
49
1.85
0.98
2.2
2.0
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
7
36
1.95
0.97
1.4
1.4
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
7
36
1.95
0.97
1.0
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
206
2283
0.87
0.97
3.6
3.2
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
12
69
1.75
0.97
1.3
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
6
28
2.15
0.91
1.5
1.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
36
272
1.34
0.88
1.8
1.7
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
14
87
1.62
0.88
1.1
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
17
112
1.53
0.85
2.5
1.7
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
14
88
1.60
0.84
1.2
1.3
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
6
31
1.94
0.84
2.5
3.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
60
490
1.24
0.83
3.1
3.1
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
8
46
1.75
0.82
3.0
1.4
g/l
0.9
1.0
—
8
46
(3021387) Prolactin [Units/volume] in Serum or Plasma
17
113
1.51
0.82
2.6
1.7
mu/l
283.4
256.5
0.15
17
104
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
16
105
1.53
0.82
1.6
1.5
%
54.0
67.9
—
9
68
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
15
97
1.56
0.81
1.8
1.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
34
259
1.33
0.81
1.8
1.6
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
12
74
1.63
0.78
1.3
1.1
—
—
—
0
0
(4211845)
6
34
1.77
0.76
2.5
3.3
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
6
34
1.77
0.76
1.0
1.1
—
14.4
—
0
5
(40767503) Oxygen content in Capillary blood by calculation
20
141
1.43
0.75
3.5
2.7
%
16.0
16.4
0.27
11
74
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
5
24
2.09
0.74
1.0
1.2
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
5
24
2.09
0.74
1.0
1.2
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
5
24
2.09
0.74
1.0
1.2
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
5
24
2.09
0.74
1.0
1.2
—
—
—
0
0
(3024263) Appearance of Synovial fluid
7
39
1.80
0.72
1.9
1.6
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
7
40
1.76
0.71
3.0
2.2
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
9
57
1.59
0.71
3.8
4.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
5
26
1.93
0.70
1.6
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
26
1.93
0.70
1.6
1.3
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
5
27
1.86
0.68
1.0
1.1
miu/ml
3050.6
1689.8
—
5
27
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
5
28
1.79
0.66
1.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
8
49
1.64
0.62
1.4
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
8
49
1.64
0.62
1.4
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
8
49
1.64
0.62
1.4
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
8
50
1.61
0.61
1.4
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
8
50
1.61
0.61
1.4
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
8
50
1.61
0.61
1.4
1.1
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
1.5
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
21
0.00
0.60
0.0
1.6
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
22
0.00
0.59
0.0
1.6
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
22
166
1.33
0.59
1.0
1.1
—
8.4
—
0
14
(3044290) Cell count panel - Cerebral spinal fluid
19
140
1.37
0.58
1.4
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
8
53
1.51
0.58
1.0
1.3
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
6
35
1.72
0.57
1.3
1.3
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
10
65
1.54
0.55
1.2
1.5
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
9
61
1.48
0.54
1.1
1.0
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
6
40
1.50
0.51
1.8
1.7
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
16
118
1.36
0.50
3.2
2.6
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
10
67
1.50
0.50
1.6
1.1
—
—
—
0
0
(4146454)
14
101
1.39
0.49
3.5
2.7
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
12
84
1.43
0.49
1.8
2.8
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
20
154
1.31
0.49
1.6
1.5
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
12
166
0.72
0.48
1.1
1.3
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
21
164
1.29
0.47
2.7
2.2
g/l
122.2
132.4
1.35
15
127
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
7
48
1.46
0.47
1.0
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
7
48
1.46
0.47
1.0
1.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
19
147
1.30
0.45
1.6
1.7
iu/l
5.8
4.9
—
5
55
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
227
2143
1.08
0.44
4.8
3.8
%
19.6
24.1
5.33
115
1015
(3006442) Creatine [Moles/volume] in Serum or Plasma
7
51
1.38
0.44
1.9
1.5
—
73.2
—
0
5
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
688
6769
1.09
0.41
4.9
4.3
mmol/l
1.4
1.3
1.18
614
6089
(1002224) Polysomnography panel
20
249
0.80
0.40
1.1
1.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
22
177
1.25
0.40
1.1
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
711
7007
1.09
0.39
5.3
4.8
mmol/l
1.4
1.5
5.38
636
6365
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
24
196
1.23
0.39
1.6
1.2
mg/l
538.9
512.6
0.19
24
186
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
5
36
1.39
0.38
2.0
2.7
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
6
42
1.43
0.35
1.8
2.6
—
—
—
0
0
(3004451) EKG impression Narrative
6
42
1.43
0.35
1.3
1.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
38
332
1.15
0.32
1.3
1.3
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
6
47
1.28
0.32
1.7
1.5
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
12
92
1.31
0.32
1.0
1.0
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
731
7228
1.08
0.31
6.1
5.5
mmol/l
2.4
2.7
6.86
657
6587
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
91
982
0.92
0.31
4.7
5.0
%
32.6
32.8
0.07
53
634
(3023410) Appearance of Cerebral spinal fluid
10
75
1.34
0.30
1.9
1.2
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
15
120
1.25
0.30
2.9
3.4
%
58.5
59.8
0.12
15
120
(3045424) Erythrocytes [Presence] in Urine
14
111
1.27
0.30
1.6
1.4
—
—
—
0
0
(4024509)
5
71
0.70
0.26
2.4
1.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
84
782
1.08
0.26
1.6
1.4
—
—
—
0
0
(3019225) pH of Specimen
79
735
1.08
0.25
4.9
3.8
—
—
—
0
0
(4034850)
24
275
0.87
0.23
12.1
10.8
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
14
116
1.21
0.22
2.6
3.2
e9/l
4.2
4.7
0.25
14
116
(3044927) Protein electrophoresis panel - Urine
13
107
1.22
0.21
1.1
1.1
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.9
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
12
0.00
0.21
0.0
2.7
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
12
0.00
0.21
0.0
2.8
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
12
0.00
0.21
0.0
1.0
—
7.1
—
0
12
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
5
43
1.16
0.21
12.6
9.4
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
13
0.00
0.21
0.0
1.6
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
6
48
1.25
0.20
1.8
2.3
%
13.2
13.3
—
6
48
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
34
309
1.10
0.18
1.9
1.6
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
35
319
1.10
0.18
2.1
1.9
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
9
80
1.13
0.15
1.0
1.3
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
30
277
1.09
0.13
1.9
1.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
57
541
1.06
0.12
4.1
3.6
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
13
147
0.88
0.11
1.4
1.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
203
1987
1.03
0.11
1.6
1.6
mmol/l
1.4
1.4
0.33
182
1653
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
711
7072
1.03
0.11
5.4
4.8
mmol/l
4.3
4.6
10.26
640
6459
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
5
44
1.14
0.10
5.0
5.6
—
35.9
—
0
10
(3014271) Vancomycin [Susceptibility]
5
45
1.11
0.10
3.2
2.8
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
6
55
1.09
0.09
2.3
1.9
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
6
57
1.05
0.08
1.5
4.6
mmol/l
6.7
7.5
—
6
32
(3003740) Influenza virus B Ag [Presence] in Specimen
5
64
0.78
0.08
1.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
5
65
0.77
0.08
1.0
1.1
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
6
71
0.84
0.07
7.0
3.1
mg/l
19.8
12.8
—
6
56
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
8
75
1.07
0.07
1.0
1.0
—
2.2
—
0
31
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
10
108
0.93
0.03
1.0
1.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
146
1466
1.00
0.00
3.1
2.7
ug/l
0.6
0.7
1.36
111
983
(3027008) Opiates [Presence] in Urine
10
104
0.96
0.00
1.1
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
10
104
0.96
0.00
1.1
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
10
103
0.97
0.00
1.1
1.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
10
103
0.97
0.00
1.1
1.3
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
19
187
1.02
0.00
1.6
1.5
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
10
99
1.01
0.00
1.1
1.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
18
175
1.03
0.00
2.3
2.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
10
95
1.05
0.00
1.5
1.3
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
8
79
1.01
0.00
1.3
2.0
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3045462) Protein/Creatinine [Ratio] in Urine
0
5
0.00
0.00
0.0
6.6
—
9.6
—
0
5
(3017509) Phencyclidine [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010015) Selenium [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
1.4
—
0
7
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
9.7
—
0
6
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
6
66
0.91
0.00
1.2
1.1
—
80.8
—
0
9
(3032700) Glomerular basement membrane Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(44806071)
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
5
52
0.96
0.00
2.2
1.5
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_DUODENUM_EXALLC – Benign neoplasm: Duodenum

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).